ECHO PHARMA LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Echo Pharma Limited. The company was founded 6 years ago and was given the registration number SC596436. The firm's registered office is in GLASGOW. You can find them at 95-107 Lancefield Street, , Glasgow, . This company's SIC code is 74909 - Other professional, scientific and technical activities n.e.c..

Company Information

Name	:	ECHO PHARMA LIMITED
Company Number	:	SC596436
Company Type	:	PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status	:	Active
Incorporation Date	:	08 May 2018
End of financial year	:	31 May 2023
Jurisdiction	:	Scotland
Industry Codes	:	74909 - Other professional, scientific and technical activities n.e.c.

Office Address & Contact

Registered Address	:	95-107 Lancefield Street, Glasgow, United Kingdom, G3 8HZ
Country Origin	:	UNITED KINGDOM
Telephone	:	Unreported
Email Address	:	Unreported
Website	:	Unreported
Social	:	Unreported

Company Officers

Personal Information	Role	Appointed	Status
159, King Street,, Rutherglen, Glasgow, Scotland, G73 1BZ	Director	08 May 2018	Active

People with Significant Control

Mr Ramzan Javed
Notified on	:	08 May 2018
Status	:	Active
Date of birth	:	May 1988
Nationality	:	British
Country of residence	:	Scotland
Address	:	159, King Street, Glasgow, Scotland, G73 1BZ
Nature of control	:	Ownership of shares 75 to 100 percent Ownership of shares 75 to 100 percent as trust Ownership of shares 75 to 100 percent as firm Voting rights 75 to 100 percent Voting rights 75 to 100 percent as trust Voting rights 75 to 100 percent as firm Right to appoint and remove directors as trust Significant influence or control as trust

Account Documents

Accounts

Last accounts submitted for period 31 March 2023 (1 year ago)
Accounts type was MICRO
Next accounts dated 31 March 2024
Due by 31 December 2024 (1 months remaining)

Confirmation Statement

Last submitted on 14 October 2023 (1 year ago)
Next confirmation dated 14 October 2024
Due by 28 October 2024 (0 months remaining)